[Estrogens following menopause. Methods of hormone replacement].
Even today hormone replacement therapy concerns still only a rather small number of post-menopausal women: 19% of women aged 50-75 on the basis of prescriptions. The compliance of oestrogen substitution reflects even more a general reticence against the use of hormones within the public opinion and among physicians. Thus, hard work for widespread information remains to be achieved, based on scientifically well established data. The purpose of this presentation is to describe benefits and drawbacks of the modes of administration of oestrogens and of oestro-progestative associations and to consider the new developments in this matter.
D000279:Administration, Cutaneous; D000282:Administration, Intravaginal; D000284:Administration, Oral; D000368:Aged; D004334:Drug Administration Schedule; D004338:Drug Combinations; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects
D004338:Drug Combinations; D011372:Progestins
Les oestrogènes après la ménopause. Les modalités de la substitution hormonale.